These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urea as an endogenous surrogate in human microdialysis to determine relative recovery of drugs: analytics and applications. Schwalbe O; Buerger C; Plock N; Joukhadar C; Kloft C J Pharm Biomed Anal; 2006 Apr; 41(1):233-9. PubMed ID: 16364587 [TBL] [Abstract][Full Text] [Related]
4. Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium. Benjamin RK; Hochberg FH; Fox E; Bungay PM; Elmquist WF; Stewart CF; Gallo JM; Collins JM; Pelletier RP; de Groot JF; Hickner RC; Cavus I; Grossman SA; Colvin OM Neuro Oncol; 2004 Jan; 6(1):65-74. PubMed ID: 14769143 [TBL] [Abstract][Full Text] [Related]
5. Microdialysis as a tool in local pharmacodynamics. Li Y; Peris J; Zhong L; Derendorf H AAPS J; 2006 Apr; 8(2):E222-35. PubMed ID: 16796373 [TBL] [Abstract][Full Text] [Related]
6. Clinical microdialysis in skin and soft tissues: an update. Schmidt S; Banks R; Kumar V; Rand KH; Derendorf H J Clin Pharmacol; 2008 Mar; 48(3):351-64. PubMed ID: 18285620 [TBL] [Abstract][Full Text] [Related]
7. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Joukhadar C; Müller M Clin Pharmacokinet; 2005; 44(9):895-913. PubMed ID: 16122279 [TBL] [Abstract][Full Text] [Related]
8. Monitoring tissue drug levels by clinical microdialysis. Müller M Altern Lab Anim; 2009 Sep; 37 Suppl 1():57-9. PubMed ID: 19807204 [TBL] [Abstract][Full Text] [Related]
12. Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives. Holmgaard R; Nielsen JB; Benfeldt E Skin Pharmacol Physiol; 2010; 23(5):225-43. PubMed ID: 20484965 [TBL] [Abstract][Full Text] [Related]
13. Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions. Azeredo FJ; Dalla Costa T; Derendorf H Clin Pharmacokinet; 2014 Mar; 53(3):205-212. PubMed ID: 24452811 [TBL] [Abstract][Full Text] [Related]
15. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop. Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942 [TBL] [Abstract][Full Text] [Related]
16. Optimizing the preclinical/clinical interface: an Informa Life Sciences conference 12-13 December, 2006, London, UK. Cavero I Expert Opin Drug Saf; 2007 Mar; 6(2):217-24. PubMed ID: 17367268 [TBL] [Abstract][Full Text] [Related]
17. Microdialysis: a technique for pharmacokinetic-pharmacodynamic studies of oncological drugs. Wei YH; Xu LZ; Shen Q; Li FZ Curr Pharm Biotechnol; 2009 Sep; 10(6):631-40. PubMed ID: 19619119 [TBL] [Abstract][Full Text] [Related]
18. Process map proposal for the validation of genomic biomarkers. Goodsaid F; Frueh F Pharmacogenomics; 2006 Jul; 7(5):773-82. PubMed ID: 16886901 [TBL] [Abstract][Full Text] [Related]
19. AAPS-FIP summary workshop report: Pharmacogenetics in individualized medicine: methods, regulatory, and clinical applications. Moridani M; Maitland-van der Zee AH; Sasaki H; McKinnon R; Fleckenstein L; Shah VP AAPS J; 2009 Jun; 11(2):214-6. PubMed ID: 19319689 [TBL] [Abstract][Full Text] [Related]
20. PDA workshop on "Quality by Design for Biopharmaceuticals: Concepts and Implementation", May 21-22, 2007, Bethesda, Maryland. Rathore AS; Devine R PDA J Pharm Sci Technol; 2008; 62(5):380-90. PubMed ID: 19055233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]